2 studies found for:    20525995 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Phase III Study of Dasatinib vs. Imatinib in Patients With Newly Diagnosed Chronic Phase CML
Condition: Myeloid Leukemia, Chronic
Interventions: Drug: Dasatinib;   Drug: Imatinib
2 Recruiting Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML
Conditions: Chronic Myeloid Leukemia in Myeloid Blast Crisis;   Untreated Adult Acute Myeloid Leukemia
Intervention: Drug: Nilotinib+AD induction

Indicates status has not been verified in more than two years